Daniel Donovan insider trades

Open-market stock purchases and sales by Daniel Donovan, Director at Intensity Therapeutics, Inc, from SEC Form 4 filings since Mar 27, 2023.

Recent trades

DateStockTradeValue
Jul 16, 2026INTS Intensity Therapeutics, IncBought (not open market)—

Companies traded

  • INTS Intensity Therapeutics, Inc: other filings, last Jul 16, 2026
  • PBLA Panbela Therapeutics, Inc: other filings, last Mar 27, 2023

Get free alerts when Daniel Donovan files a new trade →